Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cannabidiol Anticonvulsant Effects Against Lithium-Pilocarpine-Induced Status Epilepticus in Male Rats Are Mediated by Neuroinflammation Modulation and Cannabinoids 1 (CB1), But Not CB2 and GABAA Receptors.
Masoumi M, Manavi MA, Mohammad Jafari R, Mirzaei A, Hedayatyanfard K, Beigmohammadi MT, Dehpour AR. Masoumi M, et al. Among authors: beigmohammadi mt. Cannabis Cannabinoid Res. 2023 Nov 17. doi: 10.1089/can.2023.0067. Online ahead of print. Cannabis Cannabinoid Res. 2023. PMID: 37976207
Effects of nebulized hypertonic saline on inflammatory mediators in patients with severe COVID-19 pneumonia: A double-blinded randomized controlled trial.
Beigmohammadi MT, Amoozadeh L, Naghibi N, Eslami B, Fattah Ghazi S, Javaherian M, Khajeh-Azad MA, Tabatabaei B, Abdollahi A, Nazar E. Beigmohammadi MT, et al. Sci Prog. 2023 Oct-Dec;106(4):368504231203130. doi: 10.1177/00368504231203130. Sci Prog. 2023. PMID: 37787398 Free PMC article. Clinical Trial.
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial.
Talasaz AH, Sadeghipour P, Bakhshandeh H, Sharif-Kashani B, Rashidi F, Beigmohammadi MT, Moghadam KG, Rezaian S, Dabbagh A, Sezavar SH, Farrokhpour M, Abedini A, Aliannejad R, Riahi T, Yadollahzadeh M, Lookzadeh S, Rezaeifar P, Matin S, Tahamtan O, Mohammadi K, Zoghi E, Rahmani H, Hosseini SH, Mousavian SM, Abri H, Sadeghipour P, Baghizadeh E, Rafiee F, Jamalkhani S, Amin A, Mohebbi B, Parhizgar SE, Soleimanzadeh M, Aghakouchakzadeh M, Eslami V, Payandemehr P, Khalili H, Talakoob H, Tojari T, Shafaghi S, Tabrizi S, Kakavand H, Kashefizadeh A, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Ansarin K, Maleki M, Sadeghian S, Barco S, Siegerink B, Spatz ES, Piazza G, Kirtane AJ, Tassell BWV, Lip GYH, Klok FA, Goldhaber SZ, Stone GW, Krumholz HM, Bikdeli B. Talasaz AH, et al. Among authors: beigmohammadi mt. Thromb Haemost. 2023 Jul;123(7):723-733. doi: 10.1055/a-2059-4844. Epub 2023 Mar 21. Thromb Haemost. 2023. PMID: 36944357 Clinical Trial.
Safety and efficacy of pulmonary physiotherapy in hospitalized patients with severe COVID-19 pneumonia (PPTCOVID study): A prospective, randomised, single-blind, controlled trial.
Javaherian M, Shadmehr A, Keshtkar A, Beigmohammadi MT, Dabbaghipour N, Syed A, Attarbashi Moghadam B. Javaherian M, et al. Among authors: beigmohammadi mt. PLoS One. 2023 Jan 31;18(1):e0268428. doi: 10.1371/journal.pone.0268428. eCollection 2023. PLoS One. 2023. PMID: 36719885 Free PMC article. Clinical Trial.
Immunophenotyping characteristics of COVID-19 patients: Peripheral blood CD8+ HLA-DR+ T cells as a biomarker for mortality outcome.
Mirsharif ES, Chenary MR, Bozorgmehr M, Mohammadi S, Hashemi SM, Ardestani SK, Beigmohammadi MT, Abdollahi A, Sadeghipour A, Kariminia A, Tuserkani F, Ghazanfari T. Mirsharif ES, et al. Among authors: beigmohammadi mt. J Med Virol. 2023 Jan;95(1):e28192. doi: 10.1002/jmv.28192. Epub 2022 Oct 19. J Med Virol. 2023. PMID: 36192361 Free PMC article.
54 results